Within tumor subtypes, MFSD12 expression was notably enriched in LIHC compared to cholangiocarcinoma (CC) and normal controls, suggesting a subtype-specific regulatory mechanism (Figure 10E). This evidence concerns the gene MFSD12 and cholangiocarcinoma.